← Leaderboards
Mark Talan
National Institute On Aging
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Aging
Same institution · by research overlap
Others in their field
Top investigators on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barton F Haynes · Duke University$186,001,832
- David Heimbrook · Leidos Biomedical Research, Inc.$151,740,590
- Reisa A. Sperling · Banner Health$137,047,788
Research focus
Pre-ClinicalAttenuatedProgramsModalityTissuesMortality Vital StatisticsPreventResearch StudyCardiacApoptoticChronicMyocardial IschemiaAnti-InflammatoryMyocardialCoronaryPropertyExperimental ModelsHeart FailureAnimalsAffectCoronary ArteryMyocardial InfarctionLigationElderly
Grant awards (20)
Vascular type of Ehlers-Danlos Syndrome: experimental models and treatment$797,595
ZIA · FY2012 · AG · contact PI
Different Therapeutic Approaches forTreatment of Chronic Heart Failure$398,798
ZIA · FY2012 · AG · contact PI
Therapeutic Potential of EPO and its Derivatives for Reducing Blood Pressure$398,798
ZIA · FY2012 · AG · contact PI
Reduction of myocardial damage during acute ischemia$348,948
ZIA · FY2012 · AG · contact PI
Behavioral, dietary and pharmacological modalities of cardioprotection$299,098
ZIA · FY2012 · AG · contact PI
Vascular type of Ehlers-Danlos Syndrome: experimental models and treatment$812,564
ZIA · FY2011 · AG · contact PI
Different Therapeutic Approaches forTreatment of Chronic Heart Failure$435,302
ZIA · FY2011 · AG · contact PI
Reduction of myocardial damage during acute ischemia$348,242
ZIA · FY2011 · AG · contact PI
Behavioral, dietary and pharmacological modalities of cardioprotection$319,221
ZIA · FY2011 · AG · contact PI
Vascular type of Ehlers-Danlos Syndrome: experimental models and treatment$554,961
ZIA · FY2010 · AG · contact PI
Different Therapeutic Approaches forTreatment of Chronic Heart Failure$250,276
ZIA · FY2010 · AG · contact PI
Reduction of myocardial damage during acute ischemia$217,632
ZIA · FY2010 · AG · contact PI
Behavioral, dietary and pharmacological modalities of cardioprotection$184,987
ZIA · FY2010 · AG · contact PI
Vacular type of Ehlers-Danlos Syndrome: experimental models and treatment$813,198
ZIA · FY2009 · AG · contact PI
Different Therapeutic Approaches forTreatment of Chronic Heart Failure$420,153
ZIA · FY2009 · AG · contact PI
Behavioral, dietary and pharmacological modalities of cardioprotection$192,005
ZIA · FY2009 · AG · contact PI
Reduction of myocardial damage during acute ischemia$137,792
ZIA · FY2009 · AG · contact PI
Vacular type of Ehlers-Danlos Syndrome: experimental models and treatment$550,165
Z01 · FY2008 · AG · contact PI
Behavioral, dietary and pharmacological modalities of cardioprotection$113,827
Z01 · FY2008 · AG · contact PI
Reduction of myocardial damage during acute ischemia$75,885
Z01 · FY2008 · AG · contact PI